St. Jude Medical Announces FDA And European CE Mark Approval Of The QuickFlex Family Of Leads

St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) and European CE Mark approval of the QuickFlex(TM) family of left-heart leads to treat heart failure patients. The QuickFlex leads, used in CRT (cardiac resynchronization therapy), feature shorter tip and ring electrodes (used to conduct energy), reducing the length of the lead’s rigid portions.

More: continued here

Filed under: Cardiovascular on January 29th, 2008